260 related articles for article (PubMed ID: 8641177)
1. Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action.
Conover CA; Clarkson JT; Bale LK
Endocrinology; 1996 Jun; 137(6):2286-92. PubMed ID: 8641177
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3.
Conover CA
Endocrinology; 1991 Dec; 129(6):3259-68. PubMed ID: 1720092
[TBL] [Abstract][Full Text] [Related]
3. Structural and biological characterization of bovine insulin-like growth factor binding protein-3.
Conover CA; Ronk M; Lombana F; Powell DR
Endocrinology; 1990 Dec; 127(6):2795-803. PubMed ID: 1701128
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism.
Conover CA
Endocrinology; 1992 Jun; 130(6):3191-9. PubMed ID: 1375895
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts.
Conover CA; Powell DR
Endocrinology; 1991 Aug; 129(2):710-6. PubMed ID: 1713161
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity.
Conover CA; Bale LK; Durham SK; Powell DR
Endocrinology; 2000 Sep; 141(9):3098-103. PubMed ID: 10965879
[TBL] [Abstract][Full Text] [Related]
7. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies.
Conover CA; Kiefer MC; Zapf J
J Clin Invest; 1993 Mar; 91(3):1129-37. PubMed ID: 7680662
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis.
Fowlkes JL; Serra DM; Rosenberg CK; Thrailkill KM
J Biol Chem; 1995 Nov; 270(46):27481-8. PubMed ID: 7499205
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment.
Forsten KE; Akers RM; San Antonio JD
J Cell Physiol; 2001 Dec; 189(3):356-65. PubMed ID: 11748593
[TBL] [Abstract][Full Text] [Related]
11. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
Arai T; Busby W; Clemmons DR
Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
[TBL] [Abstract][Full Text] [Related]
12. Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans.
Yang YW; Yanagishita M; Rechler MM
Endocrinology; 1996 Oct; 137(10):4363-71. PubMed ID: 8828497
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes.
Kiepe D; Ulinski T; Powell DR; Durham SK; Mehls O; Tönshoff B
Kidney Int; 2002 Nov; 62(5):1591-600. PubMed ID: 12371959
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-3 inhibits porcine granulosa cell function in vitro.
Samaras SE; Hammond JM
Am J Physiol; 1995 Jun; 268(6 Pt 1):E1057-64. PubMed ID: 7541943
[TBL] [Abstract][Full Text] [Related]
15. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
16. Bioactivity of a 29-kilodalton insulin-like growth factor binding protein-3 fragment present in excess in chronic renal failure serum.
Durham SK; Mohan S; Liu F; Baker BK; Lee PD; Hintz RL; Conover CA; Powell DR
Pediatr Res; 1997 Sep; 42(3):335-41. PubMed ID: 9284274
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
Ricort JM; Binoux M
Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells.
Besset V; Le Magueresse-Battistoni B; Collette J; Benahmed M
Endocrinology; 1996 Jan; 137(1):296-303. PubMed ID: 8536626
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts.
Bach LA; Hsieh S; Brown AL; Rechler MM
Endocrinology; 1994 Nov; 135(5):2168-76. PubMed ID: 7525263
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
Devi GR; Yang DH; Rosenfeld RG; Oh Y
Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
